Publications by authors named "Ralph S Mazenko"

Claim this Profile
A
A Phase Ib Randomized Controlled Study to Evaluate the Effectiveness of a Single-Dose of the NR2B Selective N-Methyl-D-Aspartate Antagonist MK-0657 on Levodopa-Induced Dyskinesias and Motor Symptoms in Patients With Parkinson Disease.
W Joseph Herring, Christopher Assaid, Kerry Budd, Ryan Vargo, Ralph S Mazenko

Clin Neuropharmacol· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetic evaluation of rofecoxib : comparison of tablet and suspension formulations.
Jules I Schwartz, Patrick J Larson, Arturo G Porras, Kala-Jyoti Viswanathan-Aiyer, Nancy G B Agrawal, Ralph S Mazenko

Clin Drug Investig· October 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The effects of modifying in vivo cytochrome P450 3A (CYP3A) activity on etoricoxib pharmacokinetics and of etoricoxib administration on CYP3A activity.
Nancy G B Agrawal, Catherine Z Matthews, Ralph S Mazenko, Eric J Woolf, Arturo G Porras

J Clin Pharmacol· October 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Etoricoxib in acute pain associated with dental surgery: a randomized, double-blind, placebo- and active comparator-controlled dose-ranging study.
Kerstin Malmstrom, Aditi Sapre, Heather Couglin, Nancy G B Agrawal, Ralph S Mazenko

Clin Ther· May 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetics of etoricoxib in patients with renal impairment.
Nancy G B Agrawal, Catherine Z Matthews, Ralph S Mazenko, Walter F Kline, Eric J Woolf

J Clin Pharmacol· January 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis